Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05142345 · ClinicalTrials.gov registry record · NA

Care Transition Intervention for Hospitalized Patients With Advanced Cancer

A NA study of Cancer and Advanced Cancer, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
286
Enrollment target
1
Study location

NCT05142345 is a NA study of Cancer and Advanced Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 286 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05142345, a NA study of Cancer and Advanced Cancer, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
286 participants
Enrollment target
1
Study location

Study Summary

This study is examining whether a care transition intervention, CONTINUUM (CONTINUity of care Under Management by video visits), consisting of a supportive care-focused video visit with an oncology nurse practitioner (NP) within three business days of hospital discharge, may improve post-discharge transitions of care for recently hospitalized patients with advanced cancer.

Interventions

  • OTHER Usual Care
  • OTHER CONTINUUM Intervention

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital Cancer Center - Boston

Trial Details

FieldValue
Enrollment Target 286 participants
Start Date 2021-12-15
Est. Completion 2025-03-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05142345

The ClinicalTrials.gov registry entry for NCT05142345 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 286 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT05142345 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05142345 about?

NCT05142345 is a clinical study titled "Care Transition Intervention for Hospitalized Patients With Advanced Cancer". This study is examining whether a care transition intervention, CONTINUUM (CONTINUity of care Under Management by video visits), consisting of a supportive care-focused video visit with an oncology nurse practitioner (NP) within three business days of hospital discharge, may improve post-discharge t...

What is the current status of trial NCT05142345?

This trial is currently completed. It is a NA study. The enrollment target is 286 participants. The study started on 2021-12-15. Estimated completion is 2025-03-30.

What conditions does trial NCT05142345 study?

This clinical trial studies the following conditions: Cancer, Advanced Cancer, Follow-Up Care, Consultation, Remote.

What interventions are being tested in trial NCT05142345?

The interventions under investigation include: Usual Care (OTHER), CONTINUUM Intervention (OTHER).

Who is sponsoring clinical trial NCT05142345?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05142345 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.